NEUBASE THERAPEUTICS INC

CUSIP: 64132K102 Class: COM

GLENVIEW CAPITAL MANAGEMENT, LLC's Holding History (CIK: 0001138995)

Note: Option positions (PUT/CALL) are excluded.

Q1 2021
Shares 100,000 Value ($000) $739 Avg Close — Range —